Correlation Between Viscofan and Laboratorios Farmaceuticos

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viscofan and Laboratorios Farmaceuticos at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viscofan and Laboratorios Farmaceuticos into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viscofan and Laboratorios Farmaceuticos ROVI, you can compare the effects of market volatilities on Viscofan and Laboratorios Farmaceuticos and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viscofan with a short position of Laboratorios Farmaceuticos. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viscofan and Laboratorios Farmaceuticos.

Diversification Opportunities for Viscofan and Laboratorios Farmaceuticos

-0.27
  Correlation Coefficient

Very good diversification

The 3 months correlation between Viscofan and Laboratorios is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Viscofan and Laboratorios Farmaceuticos ROV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Laboratorios Farmaceuticos and Viscofan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viscofan are associated (or correlated) with Laboratorios Farmaceuticos. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Laboratorios Farmaceuticos has no effect on the direction of Viscofan i.e., Viscofan and Laboratorios Farmaceuticos go up and down completely randomly.

Pair Corralation between Viscofan and Laboratorios Farmaceuticos

Assuming the 90 days trading horizon Viscofan is expected to generate 0.75 times more return on investment than Laboratorios Farmaceuticos. However, Viscofan is 1.33 times less risky than Laboratorios Farmaceuticos. It trades about 0.02 of its potential returns per unit of risk. Laboratorios Farmaceuticos ROVI is currently generating about 0.0 per unit of risk. If you would invest  6,054  in Viscofan on September 16, 2024 and sell it today you would earn a total of  16.00  from holding Viscofan or generate 0.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Viscofan  vs.  Laboratorios Farmaceuticos ROV

 Performance 
       Timeline  
Viscofan 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viscofan has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Viscofan is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Laboratorios Farmaceuticos 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Laboratorios Farmaceuticos ROVI has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Viscofan and Laboratorios Farmaceuticos Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viscofan and Laboratorios Farmaceuticos

The main advantage of trading using opposite Viscofan and Laboratorios Farmaceuticos positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viscofan position performs unexpectedly, Laboratorios Farmaceuticos can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Laboratorios Farmaceuticos will offset losses from the drop in Laboratorios Farmaceuticos' long position.
The idea behind Viscofan and Laboratorios Farmaceuticos ROVI pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments